Tate drug page Clinical trials

Trials with Tate

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
2Countries
110Planned patients

Showing 1–1 of 1

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Recruiting Phase 2 110 patients NCT04701476

Patients with refractory metastatic colorectal cancer or non-small cell lung cancer with liver metastasis treated with Trans-arterial Tirapazamine Embolization along with Pembrolizumab.

United States, Taiwan May 2021 – Sept 2027 Interventional

Where the recruiting trials are